The draft guidance, which is touted as a way to reduce the cost and time-associated burden of biosimilar development, has ...

There are a number of considerations that can help streamline the pathway to the clinic. One of the first is which vector ...

Q1 2026 Earnings Call November 5, 2025 9:00 AM ESTCompany ParticipantsDavid Clair - VP of Investor Relations & ...

Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September ...

As drug development becomes more complex, so do the demands for accurate, reproducible bioanalytical data to prove their ...

ChemDiv, a global provider of integrated drug discovery solutions, today announced kinase inhibitor design enhancements to its discovery platform. The new capabilities strengthen support for partners ...

RetinalGenix Technologies Inc. [OTCQB: RTGN] (“RetinalGenix” or the “Company”), a company developing ultra-high-resolution retinal imaging technology, today announced it has engaged Seer, Inc. (Nasdaq ...

In this GEN webinar, a distinguished panel of experts discuss next-generation expression systems, optimized screening methods, and integrated development strategies that are enabling higher-performing ...

The FDA will undertake steps to accelerate the process of developing biosimilars, while also reducing development costs.

Serving approximately 3,000 customers across 12 facilities in the United States, Mexio, Asia and Europe, Nelson Labs is a global leader in outsourced microbiological and analytical chemistry testing ...

FDA issues new guidance to speed up biosimilar drug approvals, promising lower costs and improved access to affordable treatments.

This article examines key innovations driving scalable, high-yield purification of recombinant AAVs and how they’re helping ...